Journal of Antimicrobial Chemotherapy (1990) 25, 227-236
© 1990 The British Society for Antimicrobial Chemotherapy
research-article |
In-vitro activity of SCH39304 in comparison with amphotericin B and flaconazole
Service de Médecine et Laboratoire d'Investigation Clinique H. J. Tagnon, Institut Jules Bordet, Centre des Tumeurs de l'Université Libre de Bruxelles rue Héger-Bordet 1, 1000 Brussels, Belgium
Received 27 February 1989; accepted 25 September 1989
The in-vitro activity of SCH39304, a new imidazolc, was compared with that of amphotericin B using two media (Sabouraud dextrose and tissue culture (TC) medium) with or without 25% human serum. At an inoculum of 1·5 x 104 cfu/ml, the IC95% for amphotericin B ranged from 0·08 to 0·3 mg/l irrespective of the medium. At the same inoculum, the IC95% of the two imidazoles ranged from 0·3 to > 80 mg/l. The inoculum effect (from 1·5 x 104 to 1·5 x 105 cfu/ml) was < 1 dilution for the three antifungal agents. Serum increased the inhibitory activity (IC80%) of SCH393O4 and fluconazole but not of amphotericin B. The IC80%, IC95% and minimal fungicidal concentration (MFC) for amphotericin B usually ranged within two dilutions. Using kill curve methodology, the initial killing rate (04 h) of amphotericin B correlated with concentration (P < 0·001), and was faster in TC medium than in Sabouraud dextrose (P < 0·0006). SCH393O4 and fluconazole did not produce any significant killing over the range of concentrations tested (0·520 mg/l). SCH393O4 was similar to fluconazole.